Cytogen Inc

217330

Company Profile

  • Business description

    Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.

  • Contact

    128, Beobwon-ro
    Songpa-gu
    A-8 Floor, SK V1 GL Metrocity
    Seoul05854
    KOR

    T: +82 269251070

    http://www.cytogenlab.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    50

Stocks News & Analysis

stocks

Unconventional wisdom: Are dividends the answers?

As investors toil in complexity the obvious solution may be the right one.
stocks

Netflix: A business that’s nearly flawless

Streaming giant’s stellar results had areas of softness; currency tailwinds drive guidance raise.
stocks

Trump’s US dollar assault is fuelling CBA’s rise

A recent $1 billion investment in CBA by Texas based fund manager expresses concern for the outlook of the USD.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,934.3045.10-0.50%
CAC 407,808.929.36-0.12%
DAX 4024,107.74188.19-0.77%
Dow JONES (US)44,693.91316.38-0.70%
FTSE 1009,097.5040.87-0.45%
HKSE25,388.35278.83-1.09%
NASDAQ21,057.9637.940.18%
Nikkei 22541,456.23370.11-0.88%
NZX 50 Index12,853.4648.330.38%
S&P 5006,363.354.440.07%
S&P/ASX 2008,666.9042.50-0.49%
SSE Composite Index3,593.6612.07-0.33%

Market Movers